Emerging methods for the characterization of ischemic heart disease: ultrafast Doppler angiography, micro-CT, photon-counting CT, novel MRI and PET techniques, and artificial intelligence.
Martin J WilleminkAkos Varga-SzemesU Joseph SchoepfMarina CodariKoen NiemanDominik FleischmannDomenico MastrodicasaPublished in: European radiology experimental (2021)
After an ischemic event, disruptive changes in the healthy myocardium may gradually develop and may ultimately turn into fibrotic scar. While these structural changes have been described by conventional imaging modalities mostly on a macroscopic scale-i.e., late gadolinium enhancement at magnetic resonance imaging (MRI)-in recent years, novel imaging methods have shown the potential to unveil an even more detailed picture of the postischemic myocardial phenomena. These new methods may bring advances in the understanding of ischemic heart disease with potential major changes in the current clinical practice. In this review article, we provide an overview of the emerging methods for the non-invasive characterization of ischemic heart disease, including coronary ultrafast Doppler angiography, photon-counting computed tomography (CT), micro-CT (for preclinical studies), low-field and ultrahigh-field MRI, and 11C-methionine positron emission tomography. In addition, we discuss new opportunities brought by artificial intelligence, while addressing promising future scenarios and the challenges for the application of artificial intelligence in the field of cardiac imaging.
Keyphrases
- artificial intelligence
- computed tomography
- contrast enhanced
- positron emission tomography
- magnetic resonance imaging
- dual energy
- big data
- machine learning
- image quality
- deep learning
- high resolution
- diffusion weighted imaging
- clinical practice
- pet imaging
- magnetic resonance
- living cells
- coronary artery disease
- blood flow
- heart failure
- mesenchymal stem cells
- climate change
- optical coherence tomography
- coronary artery
- human health
- risk assessment
- current status
- stem cells
- amino acid
- systemic sclerosis
- fluorescence imaging